
The far-right Alternative for Germany (AfD) in the eastern state of Brandenburg is taking back its lawsuit against a domestic intelligence agency which had classified it as a suspected far-right extremist party six years ago, justice authorities said Friday.
The announcement was made by the Potsdam Administrative Court.
The lawsuit also referred to a mention in official reports in 2019 and 2020 by the Office for the Protection of the Constitution, which is the official name of the domestic intelligence agency.
The court said that oral arguments scheduled for January 14 and 15 will be cancelled.
The state chairman of the AfD in Brandenburg, René Springer, explained the reasons for the move: "With the classification as 'confirmed right-wing extremist' that has now taken place, the previous lawsuits against the observation as a suspected case have been settled."
There was no longer any legal basis for the proceedings, he added. The withdrawal of the lawsuit was a formal step following what Springer called a "politically motivated escalation."
"The decisive question remains the new classification," Springer asserted.
According to the court, the Brandenburg AfD's lawsuit against the classification of the regional association as a confirmed right-wing extremist organisation in 2025 will continue to be reviewed.
A date for a hearing has not yet been set.
latest_posts
- 1
Why is everyone talking about Paul Dano? George Clooney becomes the actor's latest defender in this 'time of cruelty.' - 2
The most effective method to Remain Ahead in the Most recent Advanced Patterns with a Web based Advertising Degree - 3
Involved Vehicles for Seniors: Track down the Best Picks for Solace and Unwavering quality - 4
7 Strange Apparatuses to Make Your Party Stick Out! - 5
Iran denies launching ballistic missiles towards Kurdistan region of Iraq
Middle East hotels hit pandemic-era lows amid Iran war
The Fate of Rest: Patterns in Shrewd Beds
Starship success, a private moon landing and more: The top 10 spaceflight stories of 2025
French lawmakers narrowly approve health care budget, suspending Macron's flagship pension reform
Corcept Therapeutics shares surge as lead drug gets FDA nod for ovarian cancer
Infants will no longer receive hepatitis B vaccine at birth, CDC announces
Home Machine Basics: An Exhaustive Purchasing Guide
HGV driver recruited others to smuggle migrants
What an expert on the gut microbiome eats in a day












